OTC Pharmaceuticals - Switzerland

The OTC Pharmaceuticals market in Switzerland is projected to generate a revenue of US$1.81bn by 2024.
This market is expected to experience an annual growth rate of 3.38% (CAGR 2024-2029).
Among the various categories in this market, the Other OTC Pharmaceuticals market holds the largest share with a market volume of US$655.90m in 2024.
When compared globally, the United States leads in revenue generation with US$41.24bn in 2024.
Considering the population size, the per person revenue in Switzerland is estimated to be US$204.00 in 2024.
Furthermore, online sales are projected to contribute 17.01% of the total revenue in the OTC Pharmaceuticals market by 2024.
Switzerland's OTC Pharmaceuticals market is driven by a strong demand for natural and herbal remedies.

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
Analgesics (e.g. Asprin, Paracetamol)
Cough & Cold remedies (e.g. Vicks VapoRub)
Vitamins and Minerals
Skin treatment products

Prescription medicines
Homeopathic remedies

The OTC Pharmaceuticals market in Switzerland is experiencing steady growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors.Customer preferences in Switzerland play a significant role in the growth of the OTC Pharmaceuticals market. Swiss consumers value convenience and accessibility when it comes to healthcare products. They prefer to have easy access to over-the-counter medications for common ailments such as cold and flu, allergies, and pain relief. This preference for self-care and quick relief drives the demand for OTC Pharmaceuticals in the country.Trends in the market also contribute to the growth of the OTC Pharmaceuticals market in Switzerland. One of the key trends is the increasing focus on preventive healthcare. Swiss consumers are becoming more proactive in managing their health and are willing to invest in preventive measures to avoid illnesses. This trend has led to a growing demand for OTC Pharmaceuticals that promote wellness and support a healthy lifestyle, such as vitamins and supplements.Another trend in the market is the rising popularity of natural and herbal remedies. Swiss consumers are increasingly seeking natural alternatives to traditional medications, driven by a desire for more holistic and sustainable healthcare options. This has led to a growing market for OTC Pharmaceuticals that are derived from natural ingredients and have fewer side effects.Local special circumstances also contribute to the growth of the OTC Pharmaceuticals market in Switzerland. The country has a well-developed healthcare system and a high standard of living, which means that consumers have the financial means to purchase OTC medications. Additionally, Switzerland has a strong pharmaceutical industry, with many local and international manufacturers producing OTC Pharmaceuticals. This creates a competitive market with a wide range of products available to consumers.Underlying macroeconomic factors further support the growth of the OTC Pharmaceuticals market in Switzerland. The country has a stable economy and a high level of disposable income, which enables consumers to afford OTC medications. Additionally, Switzerland has a well-established regulatory framework for OTC Pharmaceuticals, ensuring product safety and quality. This regulatory environment provides confidence to consumers and encourages them to purchase OTC medications.Overall, the OTC Pharmaceuticals market in Switzerland is experiencing growth due to customer preferences for convenience and accessibility, market trends towards preventive healthcare and natural remedies, local special circumstances such as a strong healthcare system and pharmaceutical industry, and underlying macroeconomic factors including a stable economy and robust regulatory framework.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The market has experienced significant growth during the past two decades, and pharma revenues worldwide totaled 1.48 trillion U.S. dollars in 2022.